Core Viewpoint - Chinese concept stocks experienced significant gains, with the top five performers showing substantial percentage increases in their stock prices [1] Group 1: Top Gainers - Meiyan Tang (MCTA) saw a price increase of 30.5%, closing at 9.670, with a trading volume of 3.2172 million [1] - Wangsu Technology (NPT) rose by 29.47%, closing at 6.370, with a trading volume of 3.7132 million [1] - Xiangsong International (CHSN) increased by 19.64%, closing at 2.500, with a trading volume of 292.2 thousand [1] - ChowChow Cloud International (CHOW) gained 15.83%, closing at 9.220, with a trading volume of 4.1036 million [1] - Meihua International (MHUA) rose by 15.05%, closing at 0.2561, with a trading volume of 250.6 thousand [1]

Exhibit 99.1 Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced its financial results for the fiscal year ended December 31, 2024. All amounts below are in U.S. dollars. Fiscal Year 2024 Fin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ OR ☐ SHELL COMPANY REPORT PURSUANT ...

YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced its financial results for the fiscal year ended December 31, 2024. All amounts below are in U.S. dollars.Fiscal Year 2024 Financial Metrics: Revenues remained stable and decreased slightly to $96.91 million for the year ended D ...

YANGZHOU, China, Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today reported its unaudited financial results for the six months ended June 30, 2024. All amounts below are in U.S. dollars. First Half 2024 Unaudited Financial Metrics: Revenues was approximately $45.3 million for the six months ended June 3 ...

Exhibit 99.1 INDEX TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO., LTD. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS TABLE OF CONTENTS Page | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------|-------| | Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 | F-2 | | | | | Unaudited Condensed Consol ...

YANGZHOU, China, July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced that its NT-2000 surgical path analysis system successfully supported the world's second* 5G remote robot-assisted lobectomy. This procedure, we believe the first of its kind in China's Yangzi Delta area, was performed on July 15 ...

YANGZHOU, China, July 1, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors (the "Board") has approved and authorized a share repurchase program of up to $3 million of the Company's outstanding ordinary shares (the "Share Repurchase Program"). The Company intends to cancel all ...

YANGZHOU, China, June 11, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, is pleased to announce that its management team will present and host one-on-one meetings with investors at the Sidoti Small Cap Conference, and will provide an update at the Emerging Growth Conference, both events taking place on June 13, 2024 ...

Meihua International Medical Technologies Co., Ltd. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.YANGZHOU, China, May 7, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, is pleased to announce that i ...